8.
Male 62, former smoker, had NSTEMI 4 months ago,
underwent balloon angioplasty with a drug-eluting stent; objective data: T/A
130/75MMHG, HR - 66’, EKG-no acute coronary damage detected; normal ejection
fraction; dyastolic dysfunction with relaxation abnormality, without marked
valvular pathology; medication: acetylsalicylic acid 81 mg, clopidogrel 75 mg,
rosuvastatin 15 mg. Lipid panel: total cholesterol 140 mg/dl, HDL 60 mg/dl,
triglycerides 150 mg/dl, LDL 50 mg/dl, ALT 19 mg/dl; what is your tactic of
choice in managing the lipid profile next? *